Monogram Technologies Reports Second Quarter 2024 Financial Results

Submitted FDA 510(k) Application and Passed FDA Administrative Review for the mBôs TKA SystemSecured Initial Strategic Multicenter Clinical Trial Collaboration with Shalby LimitedManagement to Host Business Update Conference Call Today at 4:30 …
Jetzt den vollständigen Artikel lesen